Al Mayadeen English

  • Ar
  • Es
  • x
Al Mayadeen English

Slogan

  • News
    • Politics
    • Economy
    • Sports
    • Arts&Culture
    • Health
    • Miscellaneous
    • Technology
    • Environment
  • Articles
    • Opinion
    • Analysis
    • Blog
    • Features
  • Videos
    • NewsFeed
    • Video Features
    • Explainers
    • TV
    • Digital Series
  • Infographs
  • In Pictures
  • • LIVE
News
  • Politics
  • Economy
  • Sports
  • Arts&Culture
  • Health
  • Miscellaneous
  • Technology
  • Environment
Articles
  • Opinion
  • Analysis
  • Blog
  • Features
Videos
  • NewsFeed
  • Video Features
  • Explainers
  • TV
  • Digital Series
Infographs
In Pictures
  • Africa
  • Asia
  • Asia-Pacific
  • Europe
  • Latin America
  • MENA
  • Palestine
  • US & Canada
BREAKING
Hamas: We salute our people who have demonstrated unparalleled pride, heroism, and honor.
Hamas: We salute our great people in the Gaza Strip, Al-Quds, the West Bank, and both inside and outside the homeland.
Hamas: We call on President Trump and the guarantor countries to compel the occupation government to fully implement the obligations of the agreement.
Hamas: We highly appreciate the efforts of the brotherly mediators in Qatar, Egypt, and Turkey, and we value the efforts of US President Donald Trump aimed at ending the war.
Hamas: We announce that an agreement has been reached, which entails an end to the war on Gaza, the withdrawal of the occupation, the entry of aid, and a prisoner exchange.
Hani al-Dali to Al Mayadeen: Allegedly, Trump is personally guaranteeing a halt to the genocide and an initial 70% withdrawal from the Gaza Strip, to be followed by a full withdrawal.
Qatari Foreign Ministry spox: Mediators say agreement reached on all terms of first phase of Gaza ceasefire.
Qatari Foreign Ministry spox: Mediators say Gaza ceasefire to include end of war, release of Israeli captives and Palestinian prisoners, and entry of aid.
Trump: Israel will withdraw their Troops to an agreed upon line as the first steps toward a Strong, Durable, and Everlasting Peace.
Trump: Israel and Hamas have both signed off on the first Phase of our Peace Plan.

FDA approval of Alzheimer's drug Aduhelm ‘rife with irregularities’

  • By Al Mayadeen English
  • Source: Agencies
  • 30 Dec 2022 10:24
3 Min Read

This comes against the backdrop of criticism as the FDA is expected to decide on approving another drug for treating the disease in January.

  • x
  • Probe: Alzheimer’s drug approval ‘rife with irregularities’
    Probe: Alzheimer’s drug approval ‘rife with irregularities’

Sources reported on Friday that the 2021 FDA's approval of an Alzheimer's drug called Aduhelm was "rife with irregularities" as an 18-month congressional investigation issued on Thursday found an "atypical collaboration" between FDA regulators and Aduhelm manufacturer, Biogen. 

According to the probe, investigators found that the company intended to "make history" when it set an "unjustifiably high" initial yearly price of $56,000 for the drug.

This comes against the backdrop of criticism as the FDA is expected to decide on approving another drug for treating the disease in January.

The report also found that there was an unusually high amount of phone exchanges between company officials and FDA delegates.

It also revealed that the company and the agency spent months preparing a report that did not account for substantial disagreement within the FDA about how to handle Aduhelm.

The report called on the agency to take "swift action" to make sure that any future approvals aren't met with "the same doubts about the integrity of FDA’s review."

Both the company and the FDA issued statements on Thursday to defend Aduhelm's approval process.

Biogen knew Aduhelm would dramatically affect Medicare. If just 250,000 patients got the drug, it would account for more than 25% of the Part B budget. If Aduhelm reached its full potential, it would cost taxpayers upward of $70 billion. pic.twitter.com/B2y46UrE95

— Damian Garde (@damiangarde) December 29, 2022

Related News

Alzheimer's drug approval optimistic amid promising results

UN report reveals cocaine in upward trend, meth market expands

Read more: Canada going as far as possible abuse with MAiD, hitting brakes needed

The FDA approved Aduhelm in 2021 under accelerated approval over the objections of its independent scientific advisors who felt the data failed to prove the drug's benefit to patients.

The company had reportedly halted two studies after results suggested that the drug wasn't giving the desired effects: slowing Alzheimer's deteriorating process. 

The FDA said the drug was efficient on the grounds that it reduced a buildup of plaque in the brain.

But three of the agency's advisors resigned in protest of these claims and the agency's then-acting chief was called for questioning. 

Medicare eventually declined to fund the drug, even after the yearly price was reduced to $28,000.

In a statement Thursday, FDA said its "decision to approve Aduhelm was based on our scientific evaluation of the data contained in the application, which is described in the approval materials. ... That said, the agency has already started implementing changes consistent with the Committee's recommendations."

On Biogen's part, it said "Alzheimer’s is a highly complex disease and we have learned from the development and launch of Aduhelm,” but that it “stands by the integrity of the actions we have taken."

Read more: Scientists develop new blood test for Alzheimer’s disease

  • Drug
  • Alzheimer's Disease

Most Read

Tucker Carlson speaks at a memorial for Charlie Kirk, Sunday, September 21, 2025, at State Farm Stadium in Glendale, Arizona (AP)

Tucker Carlson: Israeli officers gave orders on Iran inside Pentagon

  • Politics
  • 2 Oct 2025
A Hamas fighter in combat fatigues stands before the ceremony for the handover of Israeli captives to the Red Cross in Nuseirat, central Gaza Strip, Saturday, February 22, 2025 (AP)

Hamas responds to Trump plan, backs Gaza withdrawal, exchange

  • Politics
  • 3 Oct 2025
Mossad’s secret role in Aldo Moro’s 1978 murder revealed

Mossad’s secret role in Aldo Moro’s 1978 murder exposed

  • Politics
  • 5 Oct 2025
The Palestinian resistance and the people of Gaza showed that after combating Israeli aggression for two years, they remain victorious in the face of oppression (Mahdi Rteil/Al Mayadeen English)

Al-Aqsa Flood two years on, a tale of victory

  • Politics
  • 6 Oct 2025

Coverage

All
War on Gaza

Read Next

All
An Israeli armored vehicle moves on a street of a local market during a military raid in the West Bank refugee camp of Balata, Wednesday, October 8, 2025 (AP)
Politics

Israeli settlers kill Palestinian youth near Ramallah amid raids

Russian Foreign Minister Sergey Lavrov speaks during the Moscow format consultations on Afghanistan in Moscow, Russia, Tuesday, Oct. 7, 2025 (AP)
Politics

Iran interested in resuming nuclear talks: Lavrov

International Monetary Fund (IMF) Managing Director Kristalina Georgieva speaks during a news conference at the International Monetary Fund (IMF) headquarters in Washington, April 25, 2025 (AP)
Politics

IMF head flags US budget, Europe Defense spending challenges

Prime Minister of Italy Giorgia Meloni addresses the 80th session of the United Nations General Assembly, Wednesday, Sept. 24, 2025, at UN headquarters (AP)
Politics

Meloni faces ICC complaint over Gaza genocide complicity with Israelis

Al Mayadeen English

Al Mayadeen is an Arab Independent Media Satellite Channel.

All Rights Reserved

  • x
  • Privacy Policy
  • About Us
  • Contact Us
  • Authors
Android
iOS